Key result
Successful PVC ablation links to a ~12% LVEF increase regardless of structural heart disease.
Why the study?
PVC ablation in patients with LV dysfunction is usually restricted to suspected PVC-induced cardiomyopathy, leaving its benefit uncertain regardless of structural heart disease diagnosis, PVC morphology, or site of origin.
Does PVC ablation improve LVEF, BNP, and NYHA class in patients with frequent PVCs and depressed LVEF, regardless of underlying structural heart disease?
Cohort (n=80)
Yes
Does PVC ablation improve LVEF, BNP, and NYHA class in patients with frequent PVCs and depressed LVEF, regardless of underlying structural heart disease?
Successful ablation of frequent PVCs in patients with depressed LVEF significantly improves LVEF, BNP, and NYHA class, regardless of the presence of underlying structural heart disease.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“If you have a patient with frequent premature ventricular complex and primary prevention ICD indication you must first ablate, withhold the ICD implant and re-evaluate the implantation during the first to sixth month post ablation. This seems to be an appropriate and safe strategy.”
“This paper was very intriguing because it suggested that catheter ablation for frequent premature ventricular complex will improve the ejection fraction to a degree that an ICD is not needed. We all know that implantation of an ICD is also associated with potential long-term issues, especially with leads. This strategy could also potentially cut costs. Therefore, if we can avoid ICD implant with a one-time ablation procedure there is an important clinical impact for the future.”
May support PVC ablation to improve LVEF in low-EF patients irrespective of structural heart disease; leaves open causal effects pending randomized trials.
OBJECTIVES: This study aimed to assess the benefit after ablation of premature ventricular complexes (PVC) in patients with frequent PVC and left ventricular (LV) dysfunction, regardless of previous structural heart disease (SHD) diagnosis, PVC morphology, or estimated site of origin. BACKGROUND: Ablation of PVC in patients with LV dysfunction is usually restricted to patients with suspected PVC-induced cardiomyopathy. METHODS: Consecutive patients with frequent PVC and LV dysfunction accepted for ablation at 4 centers were prospectively included. Of the 80 patients included, 27 (34%) had a diagnosis of SHD. RESULTS: Successful sustained ablation (SSA) was achieved in 53 (66%) patients, and LVEF improved in these patients from 33.7 ± 8% to 43.8 ± 9.4% and 45.8 ± 10.9% at 6 and 12 months, respectively (p < 0.05), without differences related to previous diagnosis of SHD (p = 0.69). BNP decreased from 109 [64 to 242] pg/ml to 60 [25 to 170] pg/ml, 50 [14 to 130] pg/ml, and 60 [19 to 81] pg/ml at 1, 6, and 12 months (p < 0.05). Patients in NYHA class I increased from 12 (23%) to 42 (79%) at 12 months (p < 0.05). A 13% baseline PVC burden had 100% sensitivity and 85% specificity to predict an absolute increase ≥ 5% in LVEF after SSA. Although 20 patients with >13% PVC and SSA had class I indication for cardioverter defibrillator implantation, these indications were absent at 6 months post-ablation. CONCLUSIONS: Independently of the presence of SHD, the SSA of frequent PVC in patients with depressed LVEF induced a progressive clinical and functional improvement. Improvement in heart failure parameters was related to baseline PVC burden and persistence of ablation success.
No takes yet. Share an insight, caveat, or question.
Penela et al. (2013) conducted a cohort in Frequent premature ventricular complexes and left ventricular dysfunction (n=80). Premature ventricular complex ablation was evaluated on Left ventricular ejection fraction (LVEF) at 12 months (p=<0.05). Successful sustained ablation of frequent PVCs in patients with depressed LVEF increased LVEF from 33.7% to 45.8% at 12 months, independent of structural heart disease status.
Synapse has enriched 10 related papers. Consider them for comparative context: